Company Filing History:
Years Active: 2012-2018
Title: Manuel Zerbs - Innovator in Antibody Research
Introduction
Manuel Zerbs is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of antibody research, holding a total of 3 patents. His work focuses on the development of cross-neutralizing antibodies and protective peptides, which have important medical and diagnostic applications.
Latest Patents
Zerbs' latest patents include innovative technologies related to cross-neutralizing antibodies. One patent describes a cross-neutralizing antibody that comprises at least one polyspecific binding site that binds to alpha-toxin (Hla) and at least one of the bi-component toxins. This invention outlines its medical and diagnostic use, methods of producing the antibody, and includes an isolated nucleotide sequence, plasmids, and host cells used in the production process. Another patent relates to a protective peptide or a functionally active variant thereof, along with a composition comprising at least two such peptides or variants. This invention also covers methods for producing antibodies and diagnosing infections using these peptides.
Career Highlights
Throughout his career, Manuel Zerbs has worked with prominent companies in the biotechnology sector, including Intercell AG and Arsanis Biosciences GmbH. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative medical solutions.
Collaborations
Zerbs has collaborated with several professionals in his field, including Eszter Nagy and Astrid Teubenbacher. These collaborations have further enriched his research and development efforts.
Conclusion
Manuel Zerbs is a distinguished inventor whose work in antibody research has led to significant advancements in medical science. His patents and collaborations reflect his commitment to innovation and the betterment of healthcare solutions.